To highlight and review the application of artificial intelligence (AI) in kidney stone disease (KSD) for diagnostics, predicting procedural outcomes, stone passage, and recurrence rates. The systematic review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist.
This review discusses the newer advancements in AI-driven management strategies, which holds great promise to provide an essential step for personalized patient care and improved decision making. AI has been used in all areas of KSD including diagnosis, for predicting treatment suitability and success, basic science, quality of life (QOL), and recurrence of stone disease. However, it is still a research-based tool and is not used universally in clinical practice. This could be due to a lack of data infrastructure needed to train the algorithms, wider applicability in all groups of patients, complexity of its use and cost involved with it. The constantly evolving literature and future research should focus more on QOL and the cost of KSD treatment and develop evidence-based AI algorithms that can be used universally, to guide urologists in the management of stone disease.
Current urology reports. 2021 Oct 09*** epublish ***
B M Zeeshan Hameed, Milap Shah, Nithesh Naik, Bhavan Prasad Rai, Hadis Karimi, Patrick Rice, Peter Kronenberg, Bhaskar Somani
Department of Urology, Kasturba Medical College Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India., iTRUE: International Training and Research, Uro-Oncology and Endourology, Manipal, Karnataka, India. ., iTRUE: International Training and Research, Uro-Oncology and Endourology, Manipal, Karnataka, India., Department of Pharmacy, Manipal College of Pharmaceuticals, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India., Department of Urology, University Hospital Southampton NHS Trust, Southampton, UK., Hospital CUF Descobertas, Lisbon, Portugal.